Infectious diseases specialists diagnose and treat infections from bacteria, viruses, fungi, and parasites, focusing on fevers, antibiotics, and vaccines.
Send us all your questions or requests, and our expert team will assist you.
The clinical manifestations of Ebola Virus Disease follow a period known as the incubation period, the time interval between infection with the virus and the onset of symptoms. For Ebola, this period varies from 2 to 21 days. The average incubation period is typically eight to ten days. During this time, the infected individual is not contagious and cannot transmit the virus to others. This characteristic is crucial for contact tracing efforts; individuals who have been exposed but are asymptomatic are monitored for twenty-one days to ensure they do not develop the disease.
The onset of illness is often sudden and abrupt. It does not begin with a slow crescendo but rather a sharp decline in health. Non-specific, influenza-like symptoms characterize the initial phase. Patients typically experience:
Because these early symptoms mimic common tropical illnesses such as malaria, typhoid fever, or meningitis, early clinical diagnosis is exceptionally challenging. This ambiguity often allows the virus to circulate within a community or healthcare setting before it is recognized as a hemorrhagic fever, facilitating initial transmission chains.
As the disease progresses, typically between days three and five, the clinical picture worsens significantly. The virus attacks the gastrointestinal tract, leading to severe symptoms that cause rapid fluid and electrolyte loss.
This phase is critical because the immense loss of fluids leads to dehydration and shock, which are the primary causes of death. The term “hemorrhagic fever” suggests bleeding is the defining feature, but visible bleeding occurs in less than half of the patients. When it does happen, it typically manifests in the later stages of the disease. Bleeding signs may include:
In the final stages of fatal cases, patients develop multi-organ failure involving the liver and kidneys. Central nervous system involvement can lead to confusion, agitation, seizures, and coma. The immune system’s overreaction, known as a cytokine storm, contributes to vascular leakage and shock. Conversely, patients who survive often show signs of clinical improvement around the second week of illness, coinciding with the development of virus-specific antibodies.
Transmission of the Ebola virus requires direct physical contact. Unlike airborne respiratory viruses such as influenza or measles, Ebola does not spread through the air over long distances. The virus is present in high concentrations in the body fluids of symptomatic patients. Transmission occurs when these fluids come into contact with broken skin or mucous membranes (eyes, nose, mouth) of a healthy person.
Infectious body fluids include:
The risk of transmission increases as the disease progresses. In the early stages, the viral load in the blood is relatively low, but in the late stages of the disease—and at the time of death—the body is teeming with the virus. This dynamic makes caring for the critically ill and handling the bodies of the deceased the highest-risk activities.
Transmission pathways are often categorized into community and healthcare (nosocomial) settings. Understanding these pathways is essential for interrupting the chain of infection.
A complex aspect of Ebola transmission involves viral persistence. While the virus is cleared from the blood during recovery, it can hide in “immunologically privileged sites”—areas of the body where the immune system is less active. These sites include the interior of the eye, the central nervous system, and the testes.
This phenomenon poses unique challenges. A survivor who has recovered and regained their health may still harbor the virus in specific fluids. For example, relapse of the disease or transmission to a partner can occur months later. This understanding has shifted the medical perspective on Ebola from an acute event to a condition with potential chronic implications, requiring long-term follow-up and monitoring of survivors. It emphasizes the need for a sophisticated understanding of cellular sanctuaries where the virus evades complete eradication.
Indirect transmission via contaminated objects (fomites) is possible but less common than direct contact. The virus can survive on surfaces such as bedding, clothing, door handles, and medical equipment for varying durations, depending on environmental conditions. In fluids like blood, the virus can survive for several days at room temperature. However, the virus is sensitive to desiccation (drying out). Therefore, the risk from dry surfaces is lower than from wet, soiled surfaces. Nonetheless, rigorous decontamination of environments where Ebola patients have been treated is a mandatory component of outbreak control to prevent accidental exposure through fomites.
Send us all your questions or requests, and our expert team will assist you.
No, Ebola is not an airborne virus. It does not spread through the air like the flu or measles. Transmission requires direct contact with the body fluids of an infected person or objects contaminated with these fluids. While droplets from a cough or sneeze could theoretically transmit the virus if they land directly on mucous membranes, this is not the primary mode of spread.
Ebola is not a waterborne disease, so it does not spread through drinking water. However, the initial spillover into humans can occur through the consumption of bushmeat—wild animals like bats or monkeys—that are infected. Once in the human population, it spreads via body fluids, not through general food supplies.
A person infected with Ebola is not contagious during the incubation period. They only become contagious once they develop symptoms. The level of contagiousness increases with symptom severity, with the late stages of the disease and the time of death being the most infectious periods.
There is no evidence that mosquitoes or other insects can transmit the Ebola virus. Only mammals (humans, bats, non-human primates) have been shown to become infected and spread the virus.
The virus is typically cleared from the blood within a few weeks as the immune system fights it off. However, the virus can persist in specific body sites, such as the eyes, testes, and cerebrospinal fluid, for months or even years. Survivors are monitored to ensure these sites eventually clear the virus.
Your Comparison List (you must select at least 2 packages)
